How Analysts Feel About Arotech Corporation (NASDAQ:ARTX) After Decrease in Sellers?

September 16, 2018 - By Mary Gaskins

Arotech Corporation (NASDAQ:ARTX) Logo

Investors sentiment increased to 2.11 in Q2 2018. Its up 1.17, from 0.94 in 2018Q1. It is positive, as 4 investors sold Arotech Corporation shares while 5 reduced holdings. 9 funds opened positions while 10 raised stakes. 6.82 million shares or 16.49% more from 5.85 million shares in 2018Q1 were reported.
The New York-based Morgan Stanley has invested 0% in Arotech Corporation (NASDAQ:ARTX). Citadel Advisors Lc holds 11,506 shares or 0% of its portfolio. Moreover, Wells Fargo Com Mn has 0% invested in Arotech Corporation (NASDAQ:ARTX) for 1,000 shares. Dimensional Fund Advsrs Limited Partnership owns 0% invested in Arotech Corporation (NASDAQ:ARTX) for 1.73 million shares. Blackrock holds 83,748 shares or 0% of its portfolio. Lincoln Corp holds 0% or 10,119 shares in its portfolio. The Massachusetts-based Geode Cap Management Limited Liability has invested 0% in Arotech Corporation (NASDAQ:ARTX). Susquehanna Llp holds 0% of its portfolio in Arotech Corporation (NASDAQ:ARTX) for 26,457 shares. Jpmorgan Chase & Comm has 44,163 shares for 0% of their portfolio. Perritt Mgmt Inc stated it has 141,056 shares or 0.15% of all its holdings. Northern Tru holds 0% or 43,813 shares in its portfolio. The United Kingdom-based Barclays Public Llc has invested 0% in Arotech Corporation (NASDAQ:ARTX). Us State Bank De has 900 shares for 0% of their portfolio. First Manhattan Company holds 0% in Arotech Corporation (NASDAQ:ARTX) or 4 shares. Tower Research Ltd Liability Company (Trc) invested in 6,077 shares.

Since March 16, 2018, it had 2 insider purchases, and 0 sales for $73,240 activity.

The stock of Arotech Corporation (NASDAQ:ARTX) registered a decrease of 34.84% in short interest. ARTX’s total short interest was 124,000 shares in September as published by FINRA. Its down 34.84% from 190,300 shares, reported previously. With 102,500 shares average volume, it will take short sellers 1 days to cover their ARTX’s short positions. The short interest to Arotech Corporation’s float is 0.56%.

The stock increased 1.52% or $0.05 during the last trading session, reaching $3.35. About 92,185 shares traded. Arotech Corporation (NASDAQ:ARTX) has declined 8.45% since September 16, 2017 and is downtrending. It has underperformed by 24.07% the S&P500.

Arotech Corporation provides defense and security products worldwide. The company has market cap of $87.49 million. The companyÂ’s Training and Simulation division develops, makes, and markets multimedia and interactive digital solutions for engineering, use-of-force training, and operator training of military, law enforcement, security, emergency services, and other personnel. It has a 15.09 P/E ratio. This division offers simulators, systems engineering support, and software products for training vehicle operators to the United States military, government, municipalities, and private industry; weapon simulations used to train military pilots, weapon employment information used in air launched weapons, and part-task simulators to train aircrew; specialized use-of-force training simulators and systems for police, security personnel, and the military under the MILO Range trade name; and consulting and development support services under the Realtime Technologies trade name.

More important recent Arotech Corporation (NASDAQ:ARTX) news were published by: Benzinga.com which released: “25 Stocks Moving In Tuesday’s Pre-Market Session” on September 11, 2018, also Streetinsider.com published article titled: “After-Hours Stock Movers 09/10: (CDMO) (ARTX) (NTNX) Higher; (LMNR) (SONO) (MTRX) Lower (more…)”, Seekingalpha.com published: “Arotech +6.9% on $10.2M Army simulation work order” on September 10, 2018. More interesting news about Arotech Corporation (NASDAQ:ARTX) was released by: Benzinga.com and their article: “25 Stocks Moving In Friday’s Pre-Market Session” with publication date: September 07, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.